Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
An Integrated Cancer Prevention Strategy: the Viewpoint of the Leon Berard Comprehensive Cancer Center Lyon, France
Béatrice Fervers, Olivia Pérol, Christine Lasset, Nora Moumjid, Pauline Vidican, Pierre Saintigny, J. Tardy, Julien Biaudet, Valérie Bonadona, Dominique Triviaux, Philippe Marijnen, Rodolf Mongondry, Anne Cattey-Javouhey, Romain Buono, A. Bertrand, Perrine Marec‐Bérard, Christine Rousset‐Jablonski, F. Pilleul, Véronique Christophe, Magali Girodet, Delphine Praud, Marie-Laure Solodky, Hugo Crochet, Abdel Achache, Mauricette Michallet, Christelle Galvez, Anne Miermont, Damien Sebileau, Philippe Zrounba, Sophie Beaupère, Thierry Philip, Jean Yves Blay (2024). An Integrated Cancer Prevention Strategy: the Viewpoint of the Leon Berard Comprehensive Cancer Center Lyon, France. , 17(4), DOI: https://doi.org/10.1158/1940-6207.capr-23-0386.
Article24 days agoAlterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial
Elise Bonnet, Véronique Haddad, Stanislas Quesada, Kim-Arthur Baffert, Audrey Lardy-Cléaud, Isabelle Treilleux, Daniel Pissaloux, Valéry Attignon, Qing Wang, Adrien Buisson, Pierre-Étienne Heudel, Thomas Bachelot, Armelle Dufresne, Lauriane Eberst, Philippe Toussaint, Valérie Bonadona, Christine Lasset, Alain Viari, Emilie Sohier, Sandrine Paindavoine, Valérie Combaret, David Pérol, Isabelle Ray‐Coquard, Jean Yves Blay, Olivier Trédan (2022). Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial. , 12(10), DOI: https://doi.org/10.3390/jpm12101595.
Article21 days agoImmune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
Pierre-Étienne Heudel, Sylvie Chabaud, David Pérol, Aude Fléchon, Jérôme Fayette, P. Combemale, Olivier Trédan, Françoise Desseigne, Christelle de la Fouchardière, H. Boyle, M. Pérol, Thomas Bachelot, Philippe A. Cassier, Virginie Avrillon, C. Terret, Anne‐Sophie Michallet, Eve‐Marie Neidhardt‐Berard, Emmanuelle Nicolas‐Virelizier, Armelle Dufresne, Amine Belhabri, M. Brahmi, Laure Lebras, Franck E. Nicolini, Matthieu Sarabi, Pablo Maroto Rey, Alice Bonneville-Levard, Pauline Rochefort, A.-M. Provensal, Lauriane Eberst, Souad Assaad, Aurélie Swalduz, Pierre Saintigny, Philippe Toussaint, Yann Guillermin, Marie Castets, Clélia Coutzac, Pierre Méeus, Aurélien Dupré, Thierry Durand, Hugo Crochet, Béatrice Fervers, F. Gómez, Michel Rivoire, V. Grégoire, L. Claude, Catherine Chassagne‐Clément, F. Pilleul, Thomas Mognetti, Bruno Russias, Jean-Luc Soubirou, Christine Lasset, Gisèle Chvetzoff, Patrick Mehlen, Sophie Beaupère, Philippe Zrounba, I. Ray-Coquard, Jean Yves Blay (2021). Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer. , 6(1), DOI: https://doi.org/10.1016/j.esmoop.2020.100044.
Article19 days agoImmune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
Pierre-Étienne Heudel, Sylvie Chabaud, David Pérol, Aude Fléchon, Jérôme Fayette, P. Combemale, Olivier Trédan, Françoise Desseigne, Christelle de la Fouchardière, H. Boyle, M. Pérol, Thomas Bachelot, Philippe A. Cassier, Virginie Avrillon, C. Terret, Anne‐Sophie Michallet, Eve‐Marie Neidhardt‐Berard, Emmanuelle Nicolas‐Virelizier, Armelle Dufresne, Amine Belhabri, M. Brahmi, Laure Lebras, Franck E. Nicolini, Matthieu Sarabi, Pablo Maroto Rey, Alice Bonneville-Levard, Pauline Rochefort, A.-M. Provensal, Lauriane Eberst, Souad Assaad, Aurélie Swalduz, Pierre Saintigny, Philippe Toussaint, Yann Guillermin, Marie Castets, Clélia Coutzac, Pierre Méeus, Aurélien Dupré, Thierry Durand, Hugo Crochet, Béatrice Fervers, F. Gómez, Michel Rivoire, V. Grégoire, L. Claude, Catherine Chassagne‐Clément, F. Pilleul, Thomas Mognetti, Bruno Russias, Jean-Luc Soubirou, Christine Lasset, Gisèle Chvetzoff, Patrick Mehlen, Sophie Beaupère, Philippe Zrounba, I. Ray-Coquard, Jean Yves Blay (2021). Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer. , 6(1), DOI: https://doi.org/10.1016/j.esmoop.2020.100044.
Article19 days ago